Medical Device | March 17, 2022
Agilent establishes Centre for Excellence at Gujarat Technological University
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Cedars-Sinai Technology Ventures has had 114 patents issued for the fiscal year 2021 and has 511 active technologies under development, as of July 2021
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
Subscribe To Our Newsletter & Stay Updated
